PF-05212377

PF-05212377 Uses, Dosage, Side Effects, Food Interaction and all others data.

PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).

Trade Name PF-05212377
Generic PF-05212377
Type
Formula C18H20N4O2S
Weight Average: 356.44
Monoisotopic: 356.130697074
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PF-05212377
PF-05212377

Innovators Monograph

You find simplified version here PF-05212377

*** Taking medicines without doctor's advice can cause long-term problems.
Share